A static magnetic field attenuates lipopolysaccharide-induced neuro-inflammatory response via IL-6-mediated pathway

Electromagnetic Biology and Medicine

Volumn 33, Issue 2, 2014, Pages 132-138

  Shen, Li Kuo ^a,b,c   Huang, Haw Ming ^c   Yang, Po Chieh ^c   Huang, Yung Kai ^c   Wang, Peter Da Yun ^c   Leung, Ting Kai ^a,d   Chen, Chi Jen ^a,d   Chang, Wei Jen ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Endotoxin tolerance; IL 6; Lipopolysaccharide; Microglia; Neuro inflammatory; Static magnetic field

Indexed keywords

BIOELECTRIC PHENOMENA; MAMMALS;

IL-6; LIPOPOLYSACCHARIDES; MICROGLIA; NEURO-INFLAMMATORY; STATIC MAGNETIC FIELDS;

BRAIN;

INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL; BIOSYNTHESIS; BRAIN; CELL PROLIFERATION; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION; MAGNETIC FIELD; MALE; METABOLISM; MICROGLIA; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE; TOXICITY;

ANIMALS; BRAIN; CELL PROLIFERATION; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MAGNETIC FIELDS; MALE; MICE; MICROGLIA; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 84900460131     PISSN: 15368378     EISSN: 15368386     Source Type: Journal    
DOI: 10.3109/15368378.2013.794734     Document Type: Article

References (54)

1. Aldinucci, C., Garcia, J. B., Oalmi, M., et al. (2003). The effect of strongstatic magnetic field on lymphocytes. Bioelectromagnetics. 24:109-117. (Pubitemid 38622831)
2. Arendash, G. W., Sanchez-Ramos, J., Mori, T., et al. (2010). Electromagnetic field treatment protects against and reverses cognitiveimpairment in Alzheimer's disease mice. J. Alzheimers Dis. 19:191-210.
3. Bannerman, D. D., Goldblum, S. E. (1999). Direct effects of endotoxinon the endothelium: barrier function and injury. Lab. Invest. 79:1181-1199. (Pubitemid 29489444)
4. Brehmer, F., Bendix, I., Prager, S., et al. (2012). Interaction ofinflammation and hyperoxia in a rat model of neonatal white matterdamage. PLoS One 7:e49023, 1-13.
5. Cameron, B., Landreth, G. E. (2010). Inflammation, microglia, andAlzheimer's disease. Neurobiol. Dis. 37:503-509.
6. Chiu, K. H., Ou, K. L., Lee, S. Y., et al. (2007). Static magnetic fieldspromote osteoblast-like cells differentiation by decreasing the proliferationeffects of growth factors. Ann. Biomed. Eng. 35:1932-1939.
7. Cunningham, C., Wilcockson, D. C., Campion, S., et al. (2005). Centraland systemic endotoxin challenges exacerbate the local inflammatoryresponse and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25:9275-9284. (Pubitemid 41500836)
8. Dai, M., Reznik, S. E., Spray, D. C., et al. (2010). Desruisseaux MS. Persistent cognitive and motor deficits after successful antimalarialtreatment in murine cerebral malaria. Microbes Infect. 12:1198-1207.
9. Del Rey, A., Randolf, A., Wildmann, J., et al. (2009). Re-exposure toendotoxin induces differential cytokine gene expression in the rathypothalamus and spleen. Brain Behav. Immun. 23:776-783.
10. De Nicola, M., Cordisco, S., Cerella, C., et al. (2006). Magnetic fieldsprotect from apoptosis via redox alteration. Ann. New York Acad. Sci.1090:59-68. (Pubitemid 47092108)
11. Dziarski, R., Tapping, P. I., Tobias, P. S. (1998). Binding of bacterialpeptidoglycan to CD14. J. Biol. Chem. 73:8680-8690.
12. Erta, M., Quintana, A., Hidalgo, J. (2012). Interleukin-6, a majorcytokine in the central nervous system. Int. J. Biol. Sci. 8:1254-1266.
13. Fitting, C., Dhawan S., Cavaillon J. M. (2004). Compartmentalization oftolerance to endotoxin. J. Infect. Dis. 189:1295-1303.
14. Gayle, D. A., Ling, Z., Tong, C., et al. (2002). Lipopolysaccharide(LPS)- induced dopamine cell loss in culture: roles of tumor necrosisfactor-a, interleukin-1b, and nitric oxide. Develop Brain Res. 133:27-35. (Pubitemid 34146496)
15. Gasparini, L., Ennio, O., Wenk, G. L. (2004). Non-steroidal antiinflammatorydrugs (NSAIDs) in Alzheimer's Disease: old and newmechanisms of action. J. Neurochem. 91:521-536. (Pubitemid 39431148)
16. Godbout, J. P., Chen, J., Abraham, J., et al. (2005). Exaggeratedneuroinflammation and sickness behavior in aged mice followingactivation of the peripheral innate immune system. FASEB J. 19:1329-1331. (Pubitemid 41113739)
17. Hirsch, E. C., Hunot, S. (2009). Neuroinflammation in Parkinson'sdisease: a target for neuroprotection? Lancet Neurol. 8:382-397.
18. Holmes, C., Cunningham, C., Zotova, E., et al. (2009). Systemicinflammation and disease progression in Alzheimer disease. Neurol.73:768-774.
19. Huang, Y., Henry C. J., Dantzer, R., et al. (2008). Exaggerated sicknessbehavior and brain proinflammatory cytokine expression in aged micein response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging 29:1744-1753.
20. Jiang, Q., Akashi, S., Miyake, K. (2000). Lipopolysaccharide inducesphysical proximity between CD14 and Toll-like receptor 4 (TLR4)prior to nuclear translocation of NF-kappa B. J. Immunol. 165:2163-2167.
21. Kielian, T. (2006). Toll-like receptors in central nervous system glialinflammation and homeostasis. J. Neurosci. Res. 83:711-730.
22. Lin, C. T., Lee. S. Y., Chen, C. Y., et al. (2008a). Long-term continuousexposure to static magnetic field reduces lipopolysaccharide- inducedcytotoxicity of fibroblasts. Int. J. Radiat. Biol. 84:219-226.
23. Lin, S. L., Chang, W. J., Chiu, K. H., et al. (2008b). Mechanobiology ofMG63 osteoblast-like cells adaptation to static magnetic forces. Electromag. Biol. Med. 27:55-64.
24. Lin, S. L., Chang, W. J., Lin, Y. S., et al. (2009). Static magnetic fieldattenuates mortality rate of mice by increasing the production of IL-1receptor antagonist. Int. J. Radiat. Biol. 85:633-640.
25. Ling, Z., Zhu, Y., Tong, C. W., et al. (2006). Progressive dopamineneuron loss following supra-nigral lipopolysaccharide (LPS) infusioninto rats exposed to LPS prenatally. Exp. Neurol. 199:499-512. (Pubitemid 43928976)
26. Liu, B. (2006). Modulation of microglial pro-inflammatory and neurotoxicactivity for the treatment of Parkinson's disease. AAPS J. 8:E606-E621. (Pubitemid 44529195)
27. McGeer, E. G., Klegeris, A., McGeer, P. L. (2005). Inflammation, thecomplement system and the diseases of aging. Neurobiol. Aging 26:94-97.
28. Marsh, B., Stevens, S. L., Packard, A. E. B., et al. (2009). Systemiclipopolysaccharide protects the brain from ischemic injury byreprogramming the response of the brain to stroke: a critical role forIRF3. J. Neurosci. 29:9839-9849.
29. Medina, F. J., Túnez, I. (2010). Huntington's disease: the value oftranscranial meganetic stimulation. Curr. Med. Chem. 17:2482-2491.
30. Moon, D. O., Kim, K. C., Jin, C. Y., et al. (2007a). Inhibitory effects ofeicosapentaenoic acid on lipopolysaccharide-induced activation inBV2 microglia. Int. Immunopharmacol. 7:222-229.
31. Moon, D. O., Choi, Y. H., Kim, N. D., et al. (2007b). Anti-inflammatoryeffects of beta-lapachone in lipopolysaccharide-stimulated BV2microglia. Int. Immunopharmacol. 7:506-514.
32. Nava, F., Calapai, G., Facciola, G., et al. (1997). Effects of interleukin-10on water intake, locomotory activity, and rectal temperature in rattreated with endotoxin. Int. J. Immunopharmacol. 19:31-38. (Pubitemid 27259667)
33. Nguyen, M. D., Julien, J. P., Rivest, S. (2006). Innate immunity: Themissing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3:216-227.
34. Nuccitelli, S., Cerella, C., Cordisco, S., et al. (2006). Hyperpolarizationof plasma membrane of tumor cells sensitive to antiapoptotic effectsof magnetic fields. Ann. New York Acad. Sci. 1090:217-225. (Pubitemid 47092126)
35. Oberbeck, R., Kromm, A., Exton, M. S., et al. (2003). Pavlovianconditioning of endotoxin-tolerance in rats. Brain Behav. Immun. 17:20-27.
36. Ouchi, Y., Yoshikawa, E., Sekine, Y., et al. (2005). Microglial activationand dopamine terminal loss in early Parkinson's disease. Ann. Neurol.57:168-175. (Pubitemid 40179853)
37. Pang, Y., Fan, L. W., Zheng, B., et al. (2012). Dexamethasone andbetamethasone protect against lipopolysaccharide-induced braindamage in neonatal rats. Pediatr. Res. 71:552-558.
38. Perry, V. H., Newman, T. A., Cunningham, C. (2003). The impact ofsystemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4:103-112. (Pubitemid 37271380)
39. Qin, L., Wu, X., Block, M. L., et al. (2007). Crews FT. Systemic LPScauses chronic neuroinflammation and progressive neurodegeneration. Glia. 55:453-462. (Pubitemid 46383175)
40. Roman, A., Vetulani, J., Nalepa, I. (2002). Effect of combined treatmentwith paroxetine and transcranial magnetic stimulation (TMS) on themitogen-induced proliferative response of rat lymphocytes. Pol. J. Pharmacol. 54:633-639. (Pubitemid 36124513)
41. Roman, A., Zyss, T., Nalepa, I. (2005). Magnetic field inhibits isolatedlymphocytes' proliferative response to mitogen stimulation. Bioelectromagnetics. 26:201-206. (Pubitemid 40463425)
42. Rosen, A. D. (2003). Mechanism of action of moderate-intensity staticmagnetic fields on biological systems. Cell Biochem. Biophys. 39:163-173. (Pubitemid 41270802)
43. Salerno, S., Lo Casto, A., Caccamo, N., et al. (1999). Static magneticfields generated by a 0.5 T MRI unit affects in vitro expression ofactivation markers and interleukin release in human peripheral bloodmononuclear cells (PBMC). Int. J. Rad. Biol. 75:457-463. (Pubitemid 29191544)
44. Tasset, I., Medina, F. J., Jimena, I., et al. (2012). Neuroprotective effectsof extremely low-frequency electromagnetic fields on a Huntington'sdisease rat model: effects on neurotrophic factors and neuronaldensity. Neurosci. 209:54-63.
45. Tasset, I., Pérez-Herrera, A., Medina, F. J., et al. (2013). Extremelylow-frequency electromagnetic fields activate the antioxidantpathway Nrf2 in a Huntington's disease-like rat model. BrainStimul. 6:84-86.
46. Tapia-Gonzalez, S., Carrero, P., Pernia, O., et al. (2008). Selectiveoestrogen receptor (ER) modulators reduce microglia reactivityin vivo after peripheral inflammation: potential role of microglialERs. J. Endocrinol. 198:219-230. (Pubitemid 352038201)
47. Túnez, I., Drucker-Colín, R., Jimena, I., et al. (2006). Transcranialmagnetic stimulation attenuates cell loss and oxidative damage in thestriatum induced in the 3-nitropropionic model of Huntington'sdisease. J. Neurochem. 97:619-630.
48. Vallès, A., Martí, O., Armario, A. (2005). Mapping the areas sensitive tolong-term endotoxin tolerance in the rat brain: a c-fos mRNA study. J. Neurochem. 93:1177-1188. (Pubitemid 40776572)
49. Wang, Z., Sarje, A., Che, P. L., et al. (2009). Moderate strength (0.23-0.28 T) static magnetic fields (SMF) modulate signaling and differentiationin human embryonic cells. BMC Genomics. 10:356.
50. Wang, Z., Che, P. L., Du, J., et al. (2010). Static magnetic field exposurereproduces cellular effects of the Parkinson's disease drug candidateZM241385. PLoS ONE. 5:e13883.
51. Weinberger, A., Nyska, A., Giler, S. (1996). Treatment of experimentalinflammatory stnovitis with continuous magnetic field. Isr. J. Med. Sci. 32:1197-1201. (Pubitemid 27042439)
52. Woodroofe, M. N., Sarna, G. S., Wadhwa, M., et al. (1991). Detection ofinterleukin-1 and interleukin-6 in adult rat brain, following mechanicalinjury, by in vivo microdialysis: evidence of a role for microglia incytokine production. J. Neuroimmunol. 33:227-236.
53. Wuchert, F., Ott, D., Murgott, J., et al. (2008). Rat area postremamicroglial cells act as sensors for the toll-like receptor-4 agonistlipopolysaccharide. J. Neuroimmunol. 204:66-74.
54. Xue, M., Del Bigio, M. R. (2005). Immune pre-activation exacerbateshemorrhagic brain injury in immature mouse brain. J. Neuroimmunol.165:75-82. (Pubitemid 40989872)